Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 15 août 2001

    Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.

    Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss-Steider B, Haman A, Hugo P, Brousseau R, Hoang T
    Cancer Res. 2001-08-15 ;61( 16 ):6281-9

  • 15 août 2001

    PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.

    Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S, Borden K
    EMBO J. 2001-08-15 ;20( 16 ):4547-59

  • 3 août 2001

    Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.

    Hilairet S, Foord SM, Marshall FH, Bouvier M
    J. Biol. Chem. 2001-08-03 ;276( 31 ):29575-81

  • 1er août 2001

    Integrated system for high-throughput protein identification using a microfabricated device coupled to capillary electrophoresis/nanoelectrospray mass spectrometry.

    Li J, Tremblay TL, Wang C, Attiya S, Harrison DJ, Thibault P
    Proteomics 2001-08-01 ;1( 8 ):975-86

  • 1er août 2001

    The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.

    Kwok B, Koh B, Ndubuisi MI, Elofsson M, Crews CM
    Chem. Biol. 2001-08-01 ;8( 8 ):759-66

  • 1er août 2001

    Proliferative activity in Barrett’s esophagus before and after antireflux surgery.

    Chen LQ, Hu CY, Gaboury L, Pera M, Ferraro P, Duranceau AC
    Ann. Surg. 2001-08-01 ;234( 2 ):172-80

  • 1er août 2001

    Immunodomination results from functional differences between competing CTL.

    Roy-Proulx G, Meunier MC, Lanteigne AM, Brochu S, Perreault C
    Eur. J. Immunol. 2001-08-01 ;31( 8 ):2284-92

  • 1er juillet 2001

    Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease.

    Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C
    Nat. Med. 2001-07-01 ;7( 7 ):789-94

Voir plus de publications